Pediatr. Pregnant rhesus monkeys (Mucacu mulutta) at 67 to 85%' of term pregnancy were treated with betamethasone for 3 days and then delivered by cesarean section. These treated fetuses had larger lung volumes (32.6 + 1.8 ml/kg of body weight) compared to gestational age-matched controls (22.9 + 3.2 ml/kg of body weight: P < 0.025) but no alterations in surfactant properties a s measured by amniotic fluid L/S ratios, alveolar deflation stability, or lung pbosphatidylcholine. These findings suggest that betamethasone effects an increase in fetal lung volume by some method other than alteration in alveolar surfactant concentrations. Results also demonstrated an 11% increase in the collagen to elastin concentration in the treated fetuses as compared to the control animals ( P < 0.01). suggesting alterations in lung connective tissue. Morphometric studies done on the air-fixed inflated lung demonstrated a decrease in the number of alveoli Der unit volume of lung among the treated animals (0.95 + 0.07 x 10') compared to the control animals (1.19 + 0.08 x 10" P < 0.025) and a reduction in the mean surface area of the lungs of the treated animals (506 + 10 cm2 per cm3) compared to the control animals (561 + 9 cm>er cm" P < 0.005). These findings suggest that at least part of the increased maximal lung volumes is related to increased alveolar distensibility. Together, these pressure volume findings, biochemical studies, and morphometric analyses indicate that a major effect of betamethasone on the rhesus fetal lung is to alter lung connective tissue characteristics. Alterations in lung surfactant appear to be of less functional significance in this rhesus fetal model. The disparity between these findings and other animal studies might be due to differences in species, the preparation, or the method of glucocorticoid administration.
Summary
betamethasone are primarily upon lung structural characteristics.
Pregnant rhesus monkeys (Mucacu mulutta) at 67 to 85%' of term pregnancy were treated with betamethasone for 3 days and then delivered by cesarean section. These treated fetuses had larger lung volumes (32.6 + 1.8 ml/kg of body weight) compared to gestational age-matched controls (22.9 + 3.2 ml/kg of body weight: P < 0.025) but no alterations in surfactant properties a s measured by amniotic fluid L/S ratios, alveolar deflation stability, or lung pbosphatidylcholine. These findings suggest that betamethasone effects an increase in fetal lung volume by some method other than alteration in alveolar surfactant concentrations. Results also demonstrated an 11% increase in the collagen to elastin concentration in the treated fetuses as compared to the control animals ( P < 0.01). suggesting alterations in lung connective tissue. Morphometric studies done on the air-fixed inflated lung demonstrated a decrease in the number of alveoli Der unit volume of lung among the treated animals (0.95 + 0.07 x 10') compared to the control animals (1.19 + 0.08 x 10" P < 0.025) and a reduction in the mean surface area of the lungs of the treated animals (506 + 10 cm2 per cm3) compared to the control animals (561 + 9 cm>er cm" P < 0.005). These findings suggest that at least part of the increased maximal lung volumes is related to increased alveolar distensibility. Together, these pressure volume findings, biochemical studies, and morphometric analyses indicate that a major effect of betamethasone on the rhesus fetal lung is to alter lung connective tissue characteristics. Alterations in lung surfactant appear to be of less functional significance in this rhesus fetal model. The disparity between these findings and other animal studies might be due to differences in species, the preparation, or the method of glucocorticoid administration.
Speculation
Maternal betamethasone treatment produces alterations in the connective tissue properties of the developing fetal lung, which could have long-lasting effects on lung mechanical properties.
Acceleration of fetal lung development by antenatal administration of glucocorticoids has been demonstrated in a number of clinical and animal studies (2) . Most previous studies suggest that glucocorticoids act by accelerating the synthesis and release of fetal lung surfactant (2) . However, we have observed that the major effect of betamethasone on fetal rhesus lung is to increase the total lung capacity, with less significant surfactant alterations (14. 15) . In a more recent study, we compared air and saline fluidfilling characteristics in control and betamethasone-treated rhesus fetuses (21) . Increased lung volumes were observed in the steroidtreated fetuses, both during air and saline filling. This latter observation supports our hypothesis that the functional effects of rather than upon albeolar surfactant.
In this animal model, betamethasone appears to accelerate lung maturity by inducing structural changes that increase total lung volume. The question arises, however, as to the mechanism for this increase in lung capacity. Lung capacity can be increased either by making the inflatable units more distensible or by increasing the number of inflatable units (recruitment). To attempt to answer this question. we have performed morphometric analyses on lung tissue from betamethasone-treated fetuses. In addition, collagen and elastin have been extracted and quantified from aliquots of fetal lung, to determine whether or not alterations in fetal lung connective tissue elements might be associated with betamethasone treatment.
MATERIALS A N D METHODS
Fourteen pregnant rhesus monkeys (seven pairs of Macaca mulatta). matched for duration of gestation. were used for these studies. Details regarding the determination of the duration of pregnancy and the care ofthe pregnant females have been reported previously (15) . The pregnant animals were separated into two . -groups: group I mothers received isotonic saline (Med Tech. Inc.. Elwood, TX) intramuscularly (0.3 ml) daily for 3 days before preterm delivery. Group 11 mothers received I mg of betamethasone phosphate and I mg of betamethasone acetate (Celestone Soluspan; Schering Corp.. Kenilworth. N J ) intramuscularly (0.3 ml) for the same duration of time. This daily dosage. which is one-sixth that used in clinical obstetrics, was chosen on the basis that the rhesus fetal weight is about one-sixth that of the human fetus. Delivew was accom~lished bv cesarean section ir, all cases. according to previously described techniques ( 15) . Gestational age at delivery varied between 67 and 85% of term pregnancy (comparable to 28 to 34 wk of human pregnancy), with one animal from each group being delivered at 1 10. 1 15, 120, 125. 130. 135 . and 140 days' gestation. respectively. Amniotic fluid samples were obtained before delivery. The fetal trachea was clamped upon delivery to prevent spontaneous fetal lung inflation. Death occurred shortly thereafter. All data were collected without prior knowledge as to the gestational age or treatment of the animal. Fetal body weight, crown-heel length. crown-rump length. head circumference. trimmed placental weight. and sex were determined.
Upon completion of the pressure volume studies on fetal lungs. the following organs were removed, blotted dry, placed in preweighed, covered vessels and weighed to 0.01 mg on an analytical balance: lungs, adrenals, kidneys, thymus, liver, and spleen.
The amniotic fluid samples were processed and the lecithin/ sphengomyelin (L/S) ratio determined. as described previously (15) .
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BECK ET AL PRESSURE-VOLUME STUDIES distilled water (9) . Both procedures gave identical results. After After fetal death by asphyxiation, the trachea was unclamped and cannulated. Pressure volume studies were then performed with the thorax intact and by previously described methods (15) . Maximal lung capacity was achieved by inflating the lungs to 50 cm of water transpulmonary pressure (TPP) and maintaining that pressure for 4 min (15) . An inflation pressure of 50 cm of water would not be expected to cause lung damage in these fetal lungs. Indeed. we have shown that nearly identical deflation pressure volume curves can be obtained with an inflation pressure of 30 cm H,O. even when separated in time by an intermediate inflation to 50 cm H 2 0 (W. Mitzner and J. W. C. Johnson, unpublished observations). The values for pressure volume analyses were taken from the second inflation and deflation limbs. After these studies of the mechanical properties of the lung and thorax. the thorax was opened and the left and right lungs were removed and weighed. They were then separated. The right lung was utilized for biochemical studies. The left lung was used for morphometric studies.
MORPHOLO(iI(' STUDIES
After the pressure volume studies. the lungs were removed. and the right lung was used for biochemical studies. as noted above. The left lung main stem bronchus was cannulated. and the left lung was fully inflated and then deflated between 0 and 30 cm of water TPP. The lung was held at 30 cm H 2 0 pressure in a 37°C oven for 24 to 48 hr to achieve fixation. After fixation. thick coronal sections were cut from the upper and lower lobes. These sections were embedded in paraffin; 6 pm sections were cut and stained with hematoxylin and eosin. Measurements of alveolar numerical density and alveolar surface area density were then done by using a square grid. randomly placed at seven to ten different locations, and by averaging the countings. The alveolar surface area/unit volume of lung was determined as described by Weibel (29) and is directly proportional to the number of intersections of the test lines with alveolar walls and inversely proportional to the total length of the test lines. The test lines in this case are the perpendicular lines of the grid. Alveolar number per unit volume of lung was determined by counting the number of alveoli within the large square. Using the formula of Weibel and Gomez (30) . with a shape factor of 1.55. we calculated the number of alveoli per unit volume of lung tissue. BlO('HtM1CAL STUDltS. PHOSPHOI.IPID ANALYSES The right lung was weighed. homogenized. and lyophilized, as described previously (15) . Phospholipids were extracted by the method of Folch et al. (10) . as modified by Cheek (6) . Aliquots of the purified lipid extract were chromatographed in one dimension on silica gel H thin-layer plates (0.5 mm; Applied Science Laboratories. Inc.. State College. PA). using the solvent system of Goldner and Brumley (12) . After visualization with iodine vapor and scraping. phosphatidylcholine and sphingomyelin were quantified by the phosphorus assay of Parker and Peterson (24) . An aliquot of the total lipid extract was also analyzed for total phospholipid phosphorus by the same procedure (24) . Phospholipid concentrations were obtained by multiplying the phosphorus concentration by 25 (i.e., assuming an average molecular weight of 800).
D N A ANALYSES DNA analyses were performed by the fluorometric method of Kissane and Robbins (16) . as modified by Cheek (7) . using calf thymus DNA (Worthington Biochemical Corp.. Freehold, NJ) as the standard. hydrolysis in 0.1 N N~O H for 45 m h at 95°C of a preweighed amount of lyophilized lung homogenate. the supernatant fraction containing collagen and the insoluble (residue) fraction containing elastin were separated by centrifugation at 20.000 rpm (45.000 x g) for 30 min. The pellet was washed with distilled water. The two supernatants were combined. dialyzed, and lyophilized. Both fractions were then hydrolyzed in 6 N HCI for 24 hr at 1 10°C. Aliquots of these fractions from each lung were analyzed on a Durrum D500 amino acid analvzer. The amino acid com~osition of the residue fraction always corresponded to the known amino acid composition of pure elastin (28). The weight of elastin in the aliquot was computed from the total of the contributions of its amino acids (3 1). The amount of collagen present was calculated from the hydroxyproline content of the soluble fraction. This was measured either from the peak of the amino acid analysis or by colorimetric determination (4) . The amounts of elastin and collagen were calculated from the value computed from known aliquots and expressed in micrograms (pg) per milligram (mg) dry weight of lung.
DATA ANALYSIS
Statistical significance for all measurements was assessed by the paired r test; probability values of < 0.05 were considered significant.
RESULTS
Mean body weights and lengths are given in Table I . The mean body weight of the betamethasone-treated fetuses was not significantly different from that of the control (saline-treated) animals. The control group had three males (43%~), whereas the treated group had five (7 1%) . No significant differences in either the body lengths or head circumferences between the groups was noted. The mean adrenal to body weight ratio was significantly less in group I1 (betamethasone-treated) fetuses than in group 1 fetuses: however, the mean lung to body weight ratio was significantly greater in the group I1 animals compared to that of group 1. No significant differences were noted between the betamethasoneand saline-treated fetuses for the following organ weights. expressed per gram of body weight: pancreas, thymus. spleen. and kidney. However. both the pancreas to body weight and thymus 
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to body weight ratios tended to be reduced in the glucocorticoid-pressed per kilogram of body weight. The mean maximal lung treated animals as was found previously (14, 15) .
volume per kilogram of body weight at a TPP of 50 cm of water was signifcantly larger (about 40%) in the treated fetuses compared PRESSURE-VOLUME STUDIES to the controls. In addition, the absolute lung volumes at a TPP inflation of 40 cm of water and a TPP deflatron of 40 However. when differences in lung volumes were corrected by expressing partial volumes as percentages of V,,,,,50 TPP during inflation and deflation (Fig. 2) , the resulting curves were nearly superimposable. There were no significant differences between the treated and control fetuses in alveolar stability, as measured by air trapping on deflation. No significant correlations were obtained between V,,,,/body weight for groups 1 and I1 and adrenal weight/body weight, lung weight/body weight, or amniotic fluid L/S.
The individual paired values for the maximal lung volume and the residual lung volume at 15 cm HsO are given in Table 2 . The maximal lung volume per kilogram of bodyweight in the control groups increased with gestational age. whereas that in the betamethasone-treated groups remained relatively constant. Figure 3 is a composite of two low magnification photographs taken from the fixed sections from lungs of fetuses at 135 days' gestation. The overall visual perspective demonstrates the tendency for larger air spaces to be present in the lungs of the betamethasone-treated animal.
PULMONARY MORPHOMETRIC STUDIES
In an attempt to quantitate this difference. the mean number of alveoli per unit volume of lung and the mean internal surface area per unit volume of lung were determined using the mean linear intercept method. These two morphometric measurements are directly related because an increase in the number of alveoli per unit volume implies an increased surface area per unit volume. Figure 4 shows the alveolar surface area density as a function of gestational age for control and treated animals. The decrease in surface to volume ratio in the steroid-treated group is apparent.
When all gestational ages are grouped we find a mean + S.E. decrease from 561 + 9 cm2/cm" in the control group to 506 k 10 cm"cm" in the treated group (P < 0.005). This morphometric result is supported by the results of alveolar number. The number of alveoli was decreased from a mean f S.E. of 1.19 * 0.08 x 10"/cm" in the control group to 0.95 f 0.07 X IO"/cm" in the treated animals ( P < 0.025). ' C/E, PC/PL. and L/S ratios are given as a function of gestational age and treatment regimen.
BIOCHEMICAL STUDIES
' Female animals. P < 0.05. P < 0.01. significant difference in V,,,/kg of body weight or residual lung volume between males and females. Furthermore. male and female fetuses exhibit approximately the same percentage change after betamethasone treatment. Therefore, the fact that we have not found significant differences in deflation stability or amniotic fluid L/S ratios cannot be explained by differences in the sex ratio between the control and treated groups.
Another possible explanation for the discordance with other investigators may be our failure to quantitate the disaturated phosphatidylcholine content, presumably a better marker for surfactant synthesis than total lung phosphatidylcholine. However, in our previous studies we have found significant correlations between total phosphatidylcholine content and functional indices of surfactant, i.e., minimum extract surface tension values and lung deflation characteristics ( 15) .
The fact that the present study contrasts with a number of studies could be related to species differences, to differences in the intact animal, and to method of glucocorticoid administration. A number of studies have indicated that hyperinsulinemia may interfere with lung maturation and surfactant acceleration ( I l j.
We have recently ascertained that striking hyperinsulinemia occurs in our steroid-treated animal preparation (13) . This clearly would not be observed in in vitro preparations and may not occur where the glucocorticoid is administered directly to the fetus. rather than to the mother. Further studies are in progress to determine whether the hyperinsulinemia observed in this rhesus model might account for an apparent minimal effect of glucocorticoids on pulmonary surfactant.
In a previous study (15) . we found a 40%) increase in residual lung volume (V,,,,r,) and a 20% increase in the PC/PL ratio after betamethasone treatment. In the present study, we observed no significant change in V15,,r) after treatment and a smaller increase in PC/PL (16%), after maternal betamethasone administration. This recent study encompasses a broader (and earlier) gestational range (67 to 85% of pregnancy) than the previous one (75 to 85%). It is vossible that there is a gestational age difference in betamethasone sensitivity and thit this may ixplain the apparent inconsistencies in these two studies. Our inabilitv to demonstrate changes in alveolar stability (residual volumes dn deflation) and amniotic fluid L/S ratios suggest that lung surfactant changes are of lower magnitude and functional consequence than lung structural changes. It has been our hypothesis that the large increases in lung volumes are due primarily to alterations in the structural architecture ( 14. 15, 2 I) , rather than the surface lining. based on our observations that changes in residual lung volumes on deflation and lung phospholipid concentrations are much less striking. It is not clear to us how changes in alveolar surface tension could bring about such striking increases in maximal lung volumes. Bachofen er al. ( I ) noted little, if any, change in maximal lung volume of excised rabbit lungs after marked increases in alveolar surface tension were effected by rinsing with a detergent. The fact that increased lung volumes are observed even with saline filling when surfactant effects are nullified (21) provides the most positive evidence that betamethasone affects tissue elements directly.
Although the results of the present study show evidence of increased distensibility of individual alveoli. we still cannot exclude the possibility that some of the increased lung volume occurs because of an increased number of alveoli. The reason for this relates to the fact that we made no measurement of the lung volume after the lungs were fixed. Also. because the sections for morphometric analysis are cut from the fixed lung, we cannot directly relate these data to the pressure-volume curves done in the intact lungs. If we make the assumption that there were no systematic fixation differences between the control and the steroidtreated groups. then we may speculate on the degree of alveolar recruitment and distensibility. A 20% decrease in alveolar number per unit volume implies that an individual alveolus is increased in volume by about 25%. This increase in size is insufficient to account for the greater than 40%' increase in maximal lung volume found in this study and up to 100% increases found in previous work (15) . Therefore. to account for the entire increase in lung air volume, it is likely that there was also an increase in the number of alveoli recruited. However, at the present time. it is impossible to be precise regarding the mechanism of the increased lung volumes seen after betamethasone treatment. What is needed is a study where lung volumes are controlled during the fixation procedure. so that the morphometric results can be more directly related.
Dexamethasone has been reported to inhibit collagenase production. thereby decreasing collagen degradation and resulting in a net increase in collagen content (8). The betamethasone-treated fetuses in this study had increased collagen and decreased elastin concentrations compared to controls. Although these findings were not significantly different. they are similar to findings reported previously in studies on emphysematous lungs (5. 18. 25) . The fact that steroid treatment increased the C/E ratio by 11%' is consistent with some type of structural change and tends to support the morphometric data. Reduced numbers of alveoli and alveolar surface area per unit lung volume, as well as increased maximal lung volumes. have been reported in experimentally produced emphysema (18. 26. 27) . Although alterations in the C/ E ratio might be expected to cause functional alterations in the pressure-volume curve, it is very difficult to define a specific correlation. The functional effect of changes in the elastin and collagen content of lung tissue is complex. The simple model. with elastin fibers in parallel with collagen fibers arranged such that the collagen fibers are stressed only at high lung volumes (20) may be inadequate to describe the actual lung architecture. Indeed, the recent work of Snider et al. (27) shows a significant increase in maximal lung volume after elastase treatment. an increase which was considerably larger than the increase seen after collagenase treatment. In light of this work. our findings of increased maximal lung volume are consistent with an increased C/E ratio. However, with the increased C/E ratio. we also should have seen an increase in the deflation stability due to this structural alteration. We found no such change in the present study. although we did note them in a prior study. Failure to observe them in the current study might be explained by differences in gestational age.
In summary, we have collected functional data (pressure-volume characteristics), biochemical data (C/E concentration), and morphometric data, which are consistent with the hypothesis that there are significant connective tissue changes occurring in the fetal lung in response to glucocorticoid (betamethasone) therapy. The increase in C/E ratio and the increase in maximal lung volumes generally simulate human emphysema. Although these changes may be transitory ones which occur only during elevated plasma betamethasone concentrations. the process of repair after betamethasone treatment must be considered. After elastase-induced emphysema. lungs depleted of elastin will acquire a normal elastin content within 2 months, but the organization of the elastic fiber network is not restored to normal, and permanent anatomical deformity of the lung results (18) . This comparison of elastaseinduced emphysema and the effect of glucocorticoid on the developing lung should be interpreted cautiously. as there may be both quantitative and qualitative differences. However, the possibility that the comparison does have some validity should be kept in mind. Additional work will be needed to evaluate the long-term effect of the changes we have found in the present investigation.
